Healthcare
Live Price
Offline$178.46
+4.11% today
1Y Change
+51.49%
Window
Jun 25, 2025 โ Jun 18, 2026
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
HOYA Corporation (HOCPY) is a Healthcare stock with a market cap of $9.42T and listed on OTC. The stock last traded around $178.46 and up 51.5% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of +12.8%, a dividend yield of 0.9%. What stands out right now is revenue +16.2%, EPS +12.8%, free cash flow +3.0% with operating margin 29.6% and ROIC 18.9%. The dividend is present but secondary, with a yield around 0.9%. Valuation already assumes a fairly strong business story at P/E 38.0 and price/sales 10.3. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HOCPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+16.2% vs +7.6% peer median
Operating Margin
Above sector median
+29.6% vs +19.4% peer median
P/E
Near sector median
38.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +16.2% and EPS at +12.8%, with operating margin around 29.6%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +2.9% over the next 5 trading days and finished higher after 3 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +2.4% | +1.6% | -7.9% |
2026 Jan 30, 2026 | +63.0% | +0.2% | +4.7% | +6.0% |
2025 Oct 31, 2025 | +10.0% | +0.1% | +2.4% | -8.7% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HOCPY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HOCPY Max Drawdown
-16.72%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for HOCPY and SPY.

Company Overview
HOYA Corporation
Other OTC
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.